CAS 1428139-61-0: N-Cyclopropyl-5,6-dihydro-5-oxo-1H-imidazo[1,2-b][1,2,4]triazole-6-acetamide
Description:N-Cyclopropyl-5,6-dihydro-5-oxo-1H-imidazo[1,2-b][1,2,4]triazole-6-acetamide is a chemical compound characterized by its complex heterocyclic structure, which includes both imidazole and triazole rings. This compound features a cyclopropyl group, contributing to its unique reactivity and potential biological activity. The presence of the acetamide functional group suggests that it may exhibit properties typical of amides, such as hydrogen bonding capabilities, which can influence its solubility and interaction with biological targets. The 5-oxo group indicates a ketone functionality, which may play a role in its reactivity and stability. Overall, this compound is of interest in medicinal chemistry, particularly for its potential applications in drug development, where modifications to its structure can lead to variations in pharmacological properties. Its specific characteristics, such as melting point, solubility, and spectral data, would require empirical determination through experimental methods.
Formula:C9H11N5O2
InChI:InChI=1S/C9H11N5O2/c15-7(12-5-1-2-5)3-6-8(16)13-9-10-4-11-14(6)9/h4-6H,1-3H2,(H,12,15)(H,10,11,13,16)
InChI key:InChIKey=PKPZWJJIRSIMLW-UHFFFAOYSA-N
SMILES:O=C1N=C2NC=NN2C1CC(=O)NC3CC3
- Synonyms:
- N-Cyclopropyl-5,6-dihydro-5-oxo-1H-imidazo[1,2-b][1,2,4]triazole-6-acetamide
- 1H-Imidazo[1,2-b][1,2,4]triazole-6-acetamide, N-cyclopropyl-5,6-dihydro-5-oxo-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | N-Cyclopropyl-2-(5-oxo-5,6-dihydro-4H-imidazo[1,2-b][1,2,4]triazol-6-yl)acetamide REF: 3D-FC134754CAS: 1428139-61-0 | Min. 95% | - - - | Discontinued product |

N-Cyclopropyl-2-(5-oxo-5,6-dihydro-4H-imidazo[1,2-b][1,2,4]triazol-6-yl)acetamide
Ref: 3D-FC134754
1g | Discontinued | Request information | |
2g | Discontinued | Request information | |
5g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |